BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall-Reference-Cited by-同舟云学术

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall

Published:2018-05 Issue: Volume:66 Page:82-94
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Leonetti Alessandro,Facchinetti Francesco,Rossi Giulio,Minari Roberta,Conti Antonia,Friboulet Luc,Tiseo Marcello,Planchard David

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference175 articles.

1. Cancer statistics;Siegel;CA Cancer J Clin,2017

2. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, et al. editors. Cancer Statistics Review, 1975-2014 – SEER Statistics. SEER Cancer Stat Rev 1975-2014 2016. .

3. Somatic mutations affect key pathways in lung adenocarcinoma;Ding;Nature,2008

4. Genomic landscape of non-small cell lung cancer in smokers and never-smokers;Govindan;Cell,2012

5. Comprehensive molecular profiling of lung adenocarcinoma;Collisson;Nature,2014

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schisandrin C inhibits AKT1-regulated cell proliferation in A549 cells;International Immunopharmacology;2024-12

2. Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors;Future Medicinal Chemistry;2024-08-29

3. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

4. Spotlight on the treatment of non‐small cell lung cancer with rare genetic alterations and brain metastasis: Current status and future perspectives;International Journal of Cancer;2024-07-03

5. Molecular Mechanisms and Potential Predictive Biomarkers in Advanced Non-small Cell Lung Cancer: A Summary of Current and Future Trends;Archives of Surgery and Clinical Research;2024-06-27